Skip to main content

Table 3 Response per lesion location as detected on [18F]DOPA and [68 Ga]DOTA-TOC PET/CT a

From: Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy

 

Total number of lesions

Partial response

Stable disease

Progressive disease

Undetermined

DOPA tracer only

Total

27

3

2

4

18*

Liver

24*

2

1

4

17

Mesentery

2

1

1

Cardiac

1

1

DOTA tracer only

Total

10

3

1

3

3*

Liver

7*

2

1

3

1

Mediastinum

3

1

2

DOPA + DOTA tracer

Total

52

24

7

7

14

Liver

22

10

4

3

5

Bone

8

2

2

4

Mesentery

8

6

1

1

Cardiac

4

1

3

Lymph nodes

6

2

0

3

1

Pancreas

2

2

Lung

2

1

1

  1. aNo tumours with complete response were found
  2. *Significant difference found between tracers (p < .05)